Ironwood Pharmaceuticals is a biotechnology company developing and commercializing therapies for gastrointestinal and rare diseases. Its commercial product, LINZESS (linaclotide), a GC-C agonist, is FDA-approved for IBS-C, CIC, and FC in adults and pediatric patients. Ironwood is also advancing apraglutide, a GLP-2 analog, for short bowel syndrome with intestinal failure (SBS-IF), with a confirmatory Phase III trial (STARS-2) planned for 2026.
Q2 FY2026 — expected 2026-09-06
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001104659-26-020489 | EDGAR | 86K words |
| 2025-03-31 | 2024-12-31 | 0001558370-25-004072 | EDGAR | 94K words |
| 2024-02-16 | 2023-12-31 | 0001558370-24-001275 | EDGAR | 92K words |
| 2023-02-16 | 2022-12-31 | 0001558370-23-001462 | EDGAR | 78K words |
| 2022-02-18 | 2021-12-31 | 0001558370-22-001368 | EDGAR | — |
| 2021-02-17 | 2020-12-31 | 0001558370-21-001136 | EDGAR | — |
| 2020-02-13 | 2019-12-31 | 0001558370-20-000779 | EDGAR | — |
| 2019-02-25 | 2018-12-31 | 0001558370-19-001005 | EDGAR | — |
| 2018-02-22 | 2017-12-31 | 0001558370-18-000927 | EDGAR | — |
| 2017-02-22 | 2016-12-31 | 0001558370-17-000793 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001104659-26-091987 | EDGAR | 25K words |
| 2025-11-10 | 2025-09-30 | 0001104659-25-108795 | EDGAR | 28K words |
| 2025-08-11 | 2025-06-30 | 0001558370-25-011050 | EDGAR | 27K words |
| 2025-05-12 | 2025-03-31 | 0001558370-25-007406 | EDGAR | 23K words |
| 2024-11-07 | 2024-09-30 | 0001558370-24-014909 | EDGAR | 29K words |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011590 | EDGAR | 28K words |
| 2024-05-09 | 2024-03-31 | 0001558370-24-007640 | EDGAR | 24K words |
| 2023-11-09 | 2023-09-30 | 0001558370-23-018589 | EDGAR | 34K words |
| 2023-08-09 | 2023-06-30 | 0001558370-23-014242 | EDGAR | 33K words |
| 2023-05-04 | 2023-03-31 | 0001558370-23-008092 | EDGAR | 21K words |
| 2022-11-03 | 2022-09-30 | 0001558370-22-016235 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001558370-22-012191 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001104659-26-091625 | EDGAR | 7K words |
| 2026-03-11 | 0001104659-26-026123 | EDGAR | 1K words |
| 2026-02-25 | 0001104659-26-019405 | EDGAR | 9K words |
| 2026-01-02 | 0001104659-26-000057 | EDGAR | 3K words |
| 2025-12-23 | 0001104659-25-123974 | EDGAR | 4K words |
| 2025-11-26 | 0001104659-25-116217 | EDGAR | 0K words |
| 2025-11-10 | 0001104659-25-108806 | EDGAR | 8K words |
| 2025-10-10 | 0001104659-25-098523 | EDGAR | 1K words |
| 2025-09-03 | 0001104659-25-087008 | EDGAR | 1K words |
| 2025-08-07 | 0001104659-25-074972 | EDGAR | 8K words |
200 total filings indexed. 168 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001446847 |
| Ticker | IRWD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.ironwoodpharma.com |
| Listed | 2010-02-03 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IRWD (~200 tokens, structured JSON with cryptographic provenance)